Mark van Oene

Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom.

BlueGnome Ltd. provides application software services. It offers solutions for detection of copy number variation in the human genome. The firm's main application areas include analysis of constitutional samples to elucidate genetic disease, investigation of haematological malignancies and aneuploidy screening of single cells. The company was founded on October 15, 2001 and is headquartered in Saffron Walden, the United Kingdom.

Dante Labs, Inc. operates as a genetic testing laboratory. The company was founded by Andrea Riposati and Mattia Capulli in 2016 and is headquartered in New York, NY.

Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million.